Can I Take Vitamin B12 with Zepbound (Tirzepatide)?

Does vitamin B12 interact with Zepbound?

Zepbound is a once-weekly subcutaneous GIP/GLP-1 receptor agonist approved for weight management and obstructive sleep apnea [1]. Its drug interactions section lists insulin and insulin secretagogues such as sulfonylureas for hypoglycemia risk, and oral medicines whose absorption may be affected by delayed gastric emptying [1]. Vitamin B12 is not named in that section [1].

Tirzepatide is metabolized by proteolytic cleavage of the peptide backbone, beta-oxidation of the fatty diacid and amide hydrolysis, not by CYP enzymes [1]. B12 absorption depends on stomach acid to release food-bound B12 and on intrinsic factor for ileal uptake [3].

Why B12 comes up with Zepbound

Tirzepatide decreases calorie intake, likely via appetite [1]. B12 occurs naturally in animal foods and is added to fortified foods and supplements; low intake is a recognized risk factor for deficiency [3][5].

If metformin is also part of treatment, that drug has a separate and better-documented B12 effect. In the DPPOS B12 analysis (adults with prediabetes), B12 at or below 203 pg/mL was found in 4.3% of metformin users versus 2.3% of placebo at 5 years, and 7.4% versus 5.4% at 13 years (not significant); B12 at or below 298 pg/mL was 19.1% versus 9.5% at 5 years and 20.3% versus 15.6% at 13 years [2]. Each additional year of metformin use was associated with higher odds of deficiency (OR 1.13 per year, 95% CI 1.06-1.20) [2]. A 2018 review notes that metformin, PPIs and H2 blockers lower serum B12 by reducing absorption, while it remains unclear whether this raises the risk of clinical deficiency [8].

Does delayed gastric emptying change B12 absorption?

The Zepbound label says tirzepatide delays gastric emptying and may affect absorption of oral medicines; it advises monitoring drugs dependent on threshold concentrations and those with a narrow therapeutic index, such as warfarin [1]. That language addresses oral medicines in general rather than B12. Food-bound B12 needs stomach acid for release, while the synthetic B12 added to supplements and fortified foods is not protein-bound [6]. NIH ODS advises adults over 50 to get most of their B12 from fortified foods or supplements because many older adults make too little stomach acid to release food-bound B12 [6].

What dose of B12 is used?

NIH ODS sets the RDA for B12 at 2.4 mcg/day for teens 14 and older and adults, 2.6 mcg/day in pregnancy and 2.8 mcg/day while breastfeeding [6]. There is no Tolerable Upper Intake Level for B12, per NIH ODS, since no safety concern has been identified even at high doses [4]. Supplements commonly contain 500 to 1,000 mcg, far above the RDA, but the body absorbs only a small percentage of a large oral dose [4].

For diagnosed deficiency, a 2017 American Family Physician review states that oral vitamin B12 1 to 2 mg daily is as effective as intramuscular B12 for correcting anemia and neurologic symptoms in most patients; intramuscular B12 is faster and should be considered in severe deficiency or severe neurologic symptoms. The same review says people who have had bariatric surgery should take 1 mg oral B12 daily indefinitely [9].

A 2018 Cochrane review included 3 randomized trials with 153 participants followed for 3 to 4 months; oral 1,000 mcg/day normalized serum B12 as well as intramuscular B12 (low-quality evidence), and no trial measured clinical symptoms [10].

How is B12 status tested?

A 2025 American Family Physician review states that serum B12 below 180 pg/mL is diagnostic for deficiency, while 180 to 350 pg/mL is borderline and warrants a methylmalonic acid measurement, which confirms deficiency if elevated [5]. ODS notes most laboratories call a serum B12 below 200 or 250 pg/mL subnormal, and an MMA above 0.271 micromol/L suggests deficiency, though kidney impairment also raises MMA [4]. Measuring at least two of four markers (serum total B12, holotranscobalamin, homocysteine, MMA) improves sensitivity and specificity [8].

Screening average-risk adults is not recommended; the 2017 review says testing may be warranted with risk factors such as metformin for more than 4 months, PPI or H2 blocker for more than 12 months, vegan or strict vegetarian diet, age older than 75, gastric or small-intestine resection, or inflammatory bowel disease [9]. A persistently high serum B12 above 1,000 pg/mL on two measurements has been associated with solid tumors, hematologic malignancy and cardiovascular death; this is an association, not evidence that B12 supplements cause those conditions [5].